Skip to main content
. 2020 Oct 19;12:10271–10278. doi: 10.2147/CMAR.S267393

Table 4.

Multiivariate Analysis for OS

HR 95%CI P
No. of metastatic sites ≥3 3.01 1.85–4.24 0.02*
FOLFIRI vs FOLFOX 0.66 0.45–0.0.72 0.04*

Note: *Statistically significant.